Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous drug delivery
Biotech
Lundbeck ends subcutaneous migraine cohort after futility review
The Danish drugmaker switched its focus to IV delivery after seeing phase 2b data, delaying the completion of the trial in the process.
Nick Paul Taylor
Apr 1, 2025 5:00am
Glenmark bags subcutaneous checkpoint inhibitor rights
Jan 25, 2024 9:30am
Viridian looks to beat Horizon's Tepezza in thyroid eye disease
Jul 10, 2023 4:01pm
ASH: Roche records rare disease win ahead of Soliris showdown
Dec 12, 2022 8:15am
AACR: Exuma aims to be first to the clinic with subQ CAR therapy
Apr 11, 2022 11:18am
